	The impact of whole lung irradiation in lung metastatic rhabdomyosarcoma: A pooled analysis of two European trials and one European registry. Cancer Heinz AT, Heesen P, Merks JHM, Minard-Colin V, Ebinger M, Cameron AL, Harrabi S, Mandeville H, Schoot RA, Fuchs J, Guillen G, Koscielniak E, Chisholm JC, Sparber-Sauer M, Bisogno G. PMID: 42490727 [PubMed - indexed for MEDLINE]
	Barriers and facilitators to uptake lung cancer screening using low-dose computed tomography scan in high-risk people in Vietnam. Transl Behav Med Van Tran D, Van Le Q, Le Ngo L, Van Hoang D, Anh Trong Dam V, Khac Nguyen K, Thanh Thi Tran H, Manh Do H, Hong Luu H, Thanh Thi Nguyen X, Son Choi K. PMID: 42490697 [PubMed - indexed for MEDLINE]
	The current status of health literacy among caregivers of lung cancer patients:A cross-sectional survey. PLoS One Lei L, Jiang Y, Feng G, Li J, Wu D, Wang X, Xue X. PMID: 42490661 [PubMed - indexed for MEDLINE]
	Receipt of cancer care among stage IV non-small-cell lung cancer patients with and without intellectual or developmental disabilities: A population-based retrospective cohort study. Palliat Med Hansford RLW, Davis LE, Griffiths R, Horrill T, Nguyen P, Goldie CL, Hanna TP, Mahar AL. PMID: 42490651 [PubMed - as supplied by publisher]
	Feasibility of Reconstructing Survival Outcomes from Unstructured Electronic Medical Records under Japan's Next-Generation Medical Infrastructure Act: A Historical Cohort Study of Atezolizumab in Non-small Cell Lung Cancer. Drugs Real World Outcomes Nakatsui M, Nishida Y, Nozue S, Sakata Y, Azuma M, Abe R, Okamoto R, Nakagami Y, Okuno Y. PMID: 42489799 [PubMed - as supplied by publisher]
	Landmark ctDNA molecular response represents an early predictor of immunotherapy outcomes in lung cancer: A clinical validity study. Clin Cancer Res Niknafs N, Sivapalan L, Balan A, Wehr J, Pereira G, Hosseini-Nami S, Rao N, Jolly S, Velliangiri K, Beadles I, Loftus T, Chesnick B, Medina J, Xiao W, Pabani A, Marrone KA, Li QK, Murray JC, Rinaldi L, Dracopoli NC, Sausen M, Hann CL, Scott SC, Feliciano J, Lam VK, Levy B, Velculescu VE, Brahmer JR, Forde PM, Vellanki PJ, Anagnostou V. PMID: 42489696 [PubMed - as supplied by publisher]
	Recent advances in EGFR-targeted therapies for non-small cell lung cancer. Expert Opin Pharmacother Lucente L, Barcellini L, Ramella Pollone B, Filipazzi CL, Coco S, Puppo M, Marconi S, Santamaria S, Tagliamento M, Rossi G, Dellepiane C, Bennicelli E, Barletta G, Zinoli L, Genova C. PMID: 42489649 [PubMed - as supplied by publisher]
	Diagnostic Performance of Radial EBUS-Guided Cryobiopsy for Peripheral Lung Lesions: First Experience in Morocco. Clin Respir J Chrif Morand L, Bouti K, Saidi I, Fdil S, Rafik A. PMID: 42489183 [PubMed - indexed for MEDLINE]
	Safety and Efficacy of Aumolertinib as First-Line Treatment in EGFR-Mutant Lung Adenosquamous Carcinoma: A Multicenter, Single-Arm, Prospective Phase II Study (ARISE Study). MedComm (2020) Zhang L, Huang L, Huang D, Liu Z, Yu Y, Miao K, Miao Q, Zheng X, Xu Y, Chu Q, Lin G. PMID: 42488708 [PubMed]
	Prognostic significance of continuing immunotherapy beyond progression in unresectable lung adenocarcinoma. Front Immunol Hu F, Zheng L, Xu H, Pan F, Nie W, Zhong R, Lou Y, Han B, Zheng X, Zhong H, Zhang X. PMID: 42488667 [PubMed - indexed for MEDLINE]
	Innovative use of therapeutic antibodies in lung cancer: the current landscape of ADCs and other antibody-based therapies. Front Oncol Lee M, Lovly CM. PMID: 42488115 [PubMed]
	Development and validation of an interpretable machine learning model for venous thromboembolism risk prediction in patients with lung cancer: a real-world study. Front Med (Lausanne) Xia A, Liu J, Song J, Han Y, Ding B, Xie A, Liu C, Tang X, Xing W, Zhou D, Liu L, Zhou H. PMID: 42487960 [PubMed]
	Radiomics-based machine learning to evaluate immunotherapy efficacy in non-small cell lung cancer patients with bone metastases. J Med Imaging (Bellingham) Kakavand R, Forkert ND, Abbott A, Kendal J, Connell P, Yashar H, Monument MJ, Edwards WB. PMID: 42487876 [PubMed]
	Insulinoma-associated Protein-1 as a Biomarker for Diagnosis of Small Cell Lung Cancer: A Meta-analysis. Pak J Med Sci Zhai J, Qin B, Zhai J, Wang J. PMID: 42487865 [PubMed]
	Adherence to a diet with higher protein quality significantly reduces the risk of lung cancer: results from a population-based prospective study. Front Public Health Shu N, Peng L, Luo Y, Wang Y, Feng D, Zeng L, Tang J. PMID: 42487825 [PubMed - indexed for MEDLINE]
	Integrated approach of guided honest disclosure and palliative care for advanced lung cancer: impacts on emotional distress, symptom burden, and patient satisfaction. Front Public Health Huo H, Wei J, Zhang X, Li Y, Zhu X, Liu Y. PMID: 42487810 [PubMed - indexed for MEDLINE]
	Unique Presentation of Metastatic Malignant Germ Cell Tumour Diagnosed on Pleural Effusion Cytology. Cytopathology Brockmoeller S, Harinath L, Lajara S, Khader S. PMID: 42487271 [PubMed - as supplied by publisher]
	Descriptive analysis of screen-detected versus clinically diagnosed lung cancer cases: evidence of earlier stage shift and treatment differences. Intern Med J Guayco Sigcha J, Chee TM, Yang IA, Passmore L, Fong KM, Marshall HM. PMID: 42487222 [PubMed - as supplied by publisher]
	Cost-Effectiveness and Budget Impact of Lung Cancer Screening: A Systematic Review. Pharmacoeconomics Chen N, Wang S, Bai J, Franchini F, Winn KM, Hu J, Wang J, Chen G. PMID: 42487098 [PubMed - as supplied by publisher]
	First Measurement: Proactively Sparing the Immune System During SBRT to Early-Stage Lung Cancer-A Randomized Phase II Study. Int J Radiat Oncol Biol Phys Wijesooriya K, Nguyen C, Conaway MR, Read PW, Romano K, Lum LG, Thakur A, Lain DW, McLaughlin CM, Luminais CK, Wood S, Williams G, Chen J, Walker B, Sprouts D, Muller D, Ward K, Dutta S, Sanders J, Cousins D, Asare E, Nesbit E, Chavis YC, Walker KV, Janowski E, Showalter T, Larner JM. PMID: 42486309 [PubMed - as supplied by publisher]

Articles 1 - 20 / 160732

Page 1 of 8037



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy